We've moved past the era of "ChatGPT wrappers" (thank God), but the industry still treats autonomous agents like they're just chatbots with API access. They're not. When you give an AI system the ...
Morning Overview on MSN
Low-cost test aims to spot fake drugs faster
Researchers at the University of California, Riverside have developed a cheap, simple test that identifies counterfeit and substandard pills by analyzing how they dissolve, a method they call ...
Interview: As software grows more distributed and AI accelerates code creation, Umasankar Mukkara explains why resilience testing is becoming central to modern software quality.
A man breached Windsor Castle with a crossbow after his large language model (LLM)-based companion encouraged an assassination plan. A father’s question about pi evolved into more than 300 h of ...
Can free AI scanners replace enterprise SAST? Anthropic and OpenAI found 500-plus zero-days pattern-matching tools missed — and both scanners are free.
The start-up, founded by a former top SpaceX engineer, promises to help companies reduce their testing times and optimize systems. By Michael J. de la Merced Much of the technology world’s attention ...
Testing on Feb. 10-11 at Sebring International Raceway wasn’t classified as an NTT INDYCAR SERIES Open Test, but the private team test at the historic Florida circuit still provided plenty of ...
Early in the year, weak testing habits show fast. Road maps reset, delivery teams ship “small” changes that touch multiple services, and leadership wants shorter cycles without trading away ...
Monday - Friday, 1:00 - 2:00 PM ET It's true that the world was overly flooded with "software-as-a-service" companies over the past fifteen years. The question now, is who survives. The rise of "Saas" ...
Putting a new French pattern head knife to the test with clean cuts and smooth slicing. Featuring a knife made by Scott Teaschner and sharp right out of the box. #LeatherKnife #ToolTest #LeatherTools ...
Background: Biomarker testing is essential for guiding first-line treatment decisions in metastatic non–small cell lung cancer (mNSCLC). Despite guideline recommendations, real-world testing patterns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results